Gordon, B., Cool, L., Muhowski, E., Yu, L., Ravikrishnan, J., Benrashid, S., Mitchell, A., He, A., Misra, S., Lai, T., Thangavadivel, S., Marr, A., Urrutia, J., Leimbach, C., Karnati, N., Zhao, S. L., Sonam, S., Kumari, S., Perry, E., Rogers, K., Kittai, A., Bhat, S., Alsouqi, A., Muthusamy, N., Byrd, J., Sampath, D., Lapalombella, R., Peterson, B., Chen, Y., Anthony, S., Chen, Y., Woyach, J. (2025). Targeting BTKi-resistant CLL using the dual irreversible/reversible 4th generation BTK inhibitor rocbrutinib. Blood. https://doi.org/10.1182/blood-2025-1532